Literature DB >> 36269741

Prevalence of cancer in relation to signs of periodontal inflammation.

Jukka H Meurman1, Håkan Källmén2, Leif C Andersson3, Tulay Yucel-Lindberg4, Birgitta Söder4.   

Abstract

We investigated the associations between periodontal inflammation (gingivitis and periodontitis) and all-kind malignancies, specifically breast and prostate cancer, in a cohort followed-up for 30 years. The study hypothesis was based on the oral inflammation vs. systemic health paradigm. A sample of 2,168 subjects from an original cohort of 105,718 individuals from the greater Stockholm area in Sweden that had been followed since 1985 was investigated. Swedish national health registers were used in the study. Chi-square tests and logistic multiple regression analyses were conducted. The results showed that periodontitis was significantly associated with any cancer after adjusting for gender, age, income, and education (p = 0.015). The probability of getting cancer increased on average by 38% if the patient had periodontitis vs. had not; the odds ratio was 1.380 (95% confidence interval l.066-1.786). No significant association was observed between periodontitis and breast cancer (p = 0.608), while the association between periodontitis and prostate cancer tended towards significance (p = 0.082). However, no statistically significant difference was found between the observed and the calculated distribution of any cancer in gingivitis groups (p = 0.079). Thus, the study hypothesis was partly confirmed by showing a statistically significant association between periodontitis and any cancer.

Entities:  

Year:  2022        PMID: 36269741      PMCID: PMC9586347          DOI: 10.1371/journal.pone.0276375

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  36 in total

1.  Subgingival microbial profiles in refractory periodontal disease.

Authors:  Sigmund S Socransky; Claire Smith; Anne D Haffajee
Journal:  J Clin Periodontol       Date:  2002-03       Impact factor: 8.728

Review 2.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012.

Authors:  Paul I Eke; Bruce A Dye; Liang Wei; Gary D Slade; Gina O Thornton-Evans; Wenche S Borgnakke; George W Taylor; Roy C Page; James D Beck; Robert J Genco
Journal:  J Periodontol       Date:  2015-02-17       Impact factor: 6.993

4.  Periodontal disease may associate with breast cancer.

Authors:  Birgitta Söder; Maha Yakob; Jukka H Meurman; Leif C Andersson; Björn Klinge; Per-Östen Söder
Journal:  Breast Cancer Res Treat       Date:  2010-10-20       Impact factor: 4.872

5.  Chronic periodontitis and the incidence of head and neck squamous cell carcinoma.

Authors:  Mine Tezal; Maureen A Sullivan; Andrew Hyland; James R Marshall; Daniel Stoler; Mary E Reid; Thom R Loree; Nestor R Rigual; Mihai Merzianu; Linda Hauck; Cheryl Lillis; Jean Wactawski-Wende; Frank A Scannapieco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09       Impact factor: 4.254

6.  Evaluation of serum concentrations of hs-CRP and Hb in varying severities of chronic periodontitis.

Authors:  Linith Valiyaveetil Karattil; Reshma S Joseph; Majo Ambooken; Jayan Jacob Mathew
Journal:  Biomarkers       Date:  2022-02-02       Impact factor: 2.658

7.  Is periodontitis a risk indicator for cancer? A meta-analysis.

Authors:  Stefano Corbella; Paolo Veronesi; Viviana Galimberti; Roberto Weinstein; Massimo Del Fabbro; Luca Francetti
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

Review 8.  Periodontal disease and cancer: Epidemiologic studies and possible mechanisms.

Authors:  Ngozi Nwizu; Jean Wactawski-Wende; Robert J Genco
Journal:  Periodontol 2000       Date:  2020-06       Impact factor: 7.589

Review 9.  Genome-Wide Sex and Gender Differences in Cancer.

Authors:  Camila M Lopes-Ramos; John Quackenbush; Dawn L DeMeo
Journal:  Front Oncol       Date:  2020-11-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.